Permanent His Bundle Pacing: A Good Unconventional Mode of Right Ventricular Pacing?

  • E. Occhetta
  • M. Bortnik
  • G. Francalacci
  • A. Magnani
  • C. PIccinino
  • C. Vassanelli
Conference paper


Atrial fibrillation (AF) is the most common arrhythmia, affecting more than 1% of the general population [1], and it is usually associated with several different cardiac and noncardiac conditions, including hypertension, ischemic heart disease, cardiomyopathy, and valvular heart disease. In some patients without structural heart disease it is called “lone atrial fibrillation.” Atrial fibrillation can be classified as paroxysmal when it terminates spontaneously, persistent when it requires pharmacological or electric cardioversion to be terminated, and permanent when all attempts to terminate it fail.


Atrial Fibrillation Ventricular Outflow Tract Ventricular Pace Chronic Atrial Fibrillation Biventricular Pace 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Benjamin EJ et al (1994) Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA 271:840–844Google Scholar
  2. 2.
    Curtis AB et al (2000) Prevalence and characteristics of escape rhythms after radio-frequency ablation of the atrioventricular junction: results from the registry for AV junction ablation and pacing in atrial fibrillation. Am Heart J 139:122–125PubMedCrossRefGoogle Scholar
  3. 3.
    Brignole M et al (1997) Assessment of atrioventricular junction ablation and DDDR mode-switching pacemaker versus pharmacological treatment in patients with severely symptomatic paroxysmal atrial fibrillation. A randomized controlled study (PAF). Circulation 96:2617–2624PubMedCrossRefGoogle Scholar
  4. 4.
    Brignole M et al (2002) An evaluation of the strategy of maintenance of sinus rhythm by antiarrhythmic drug therapy after ablation and pacing therapy in patients with paroxysmal atrial fibrillation (PAF 2). Eur Heart J 23:892–900PubMedCrossRefGoogle Scholar
  5. 5.
    Gaita F et al (2000) PIPAF study: improvements during a multi-site atrial pacing experience. Europace Suppl l(suppl D):D218 (abstract)Google Scholar
  6. 6.
    Brignole M et al (1998) Assessment of atrioventricular junction ablation and VVIR pacemaker versus pharmacological treatment in patients with heart failure and chronic atrial fibrillation. A randomized controlled study. Circulation 98:953–960PubMedCrossRefGoogle Scholar
  7. 7.
    Sassone B et al (2001) Pacemaker-induced mitral régurgitation: prominent role of abnormal ventricular activation sequence versus altered atrioventricular synchrony. Ital Heart J 2:441–448PubMedGoogle Scholar
  8. 8.
    Disney PJS et al (2003) Biventricular pacing for severe mitral regurgitation following atrioventricular nodal ablation. Pacing Clin Electrophysiol 26[2-Pt I]:643–644PubMedCrossRefGoogle Scholar
  9. 9.
    De Cock CC et al (1998) Hemodynamic benefits of right ventricular outflow tract pacing: comparison with right ventricular apex pacing. Pacing Clin Electrophysiol 21:536–541PubMedCrossRefGoogle Scholar
  10. 10.
    Gold MR et al (1997) The acute hemodynamic effects of right ventricular septal pacing in patients with congestive heart failure secondary to ischemic or idiopathic dilated cardiomiopathy. Am J Cardiol 79:679–681PubMedCrossRefGoogle Scholar
  11. 11.
    Zamparelli L, Cioffi L, Di Costanzo A et al (2003) Dual-site right ventricular pacing in heart failure patients. In: Gulizia M (ed) New advances in heart failure and atrial fibrillation. Springer, Milan, pp 401–404CrossRefGoogle Scholar
  12. 12.
    Cazeau S et al, for the MUSTIC Study Investigators (2001) Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 344:873–880PubMedCrossRefGoogle Scholar
  13. 13.
    Auricchio A et al, for the PATH-CHF Study Investigators (2002) Long-term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay. J Am Coll Cardiol 39:2026–2033PubMedCrossRefGoogle Scholar
  14. 14.
    Sutton MJSJ et al, for the MIRACLE Study Investigators (2003) Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure. Circulation 107:1985–1990CrossRefGoogle Scholar
  15. 15.
    Brignole M, Gammage M (2001) An assessment of the optimal ventricular pacing site in patients undergoing “ablate and pace” therapy for permanent atrial fibrillation. Europace 3:153–156PubMedCrossRefGoogle Scholar
  16. 16.
    Deshmukh P et al (2000) Permanent, direct His bundle pacing. A novel approach to cardiac pacing in patients with normal His-Purkinje activation. Circulation 101:869–877PubMedCrossRefGoogle Scholar
  17. 17.
    Padeletti L et al (2000) Permanent His bundle pacing in man: a comparison with right ventricular apical pacing. Pacing Clin Electrophysiol 23:679 (abstract)CrossRefGoogle Scholar
  18. 18.
    Shwaab B et al (2001) Septal lead implantation for the reduction of paced QRS duration using passive fixation leads. Pacing Clin Electrophysiol 24:28–33CrossRefGoogle Scholar
  19. 19.
    Occhetta E et al (2002) “Ablate and pace” in chronic atrial fibrillation: intraventricu-lar high septal VVIR pacing to perform a “physiological” ventricular synchronization. Gior Ital Aritmol Cardiostimol 5(suppl 1):256–260Google Scholar
  20. 20.
    Occhetta E et al (2003) Permanent hisian pacing after AV node RF ablation in chronic atrial fibrillation: preliminary results of a feasibility and efficacy study. Pacing Clin Electrophysiol 26 (4-part II):1121 (abstract).Google Scholar

Copyright information

© Springer-Verlag Italia 2004

Authors and Affiliations

  • E. Occhetta
    • 1
  • M. Bortnik
    • 1
  • G. Francalacci
    • 1
  • A. Magnani
    • 1
  • C. PIccinino
    • 1
  • C. Vassanelli
    • 1
  1. 1.Division of Cardiology, School of MedicineUniversità degli Studi del Piemonte OrientaleNovaraItaly

Personalised recommendations